🇳🇬 #7 Export Destination

Nigeria

India's pharmaceutical partnership with Nigeria

$727M FY 2025–26

India ships $727M in pharmaceutical products to Nigeria each year, making it the #7 export destination. Exports have grown 2.1× over the past decade.

All data from DGCIS India export records (fiscal year, April–March).
$727M
Scale
India supplies $727M in pharmaceutical products to Nigeria each year — a substantial supply line of affordable medicine.
66%
Medicine
Primarily medicines (66%), supplemented by vaccines and medicine ingredients.
2.1×
Trajectory
India's pharmaceutical supply to Nigeria has grown 2.1× over the past decade — strong, sustained expansion.
#7
Context
A top-10 export destination, and a key pharmaceutical market in Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Nigeria — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix — FY 2025–26 DGCIS
Medicines $482M (66.2%) Vaccines $169M (23.2%) Medicine Ingredients $64.4M (8.9%) Surgical & Hospital Supplies $6.4M (0.9%) Traditional & Herbal $5.9M (0.8%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Nigeria Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Nigeria: $17.0M across 36 filings (2011-2025).